Name: UMIN ID:
Unique ID issued by UMIN | C000000207 |
---|---|
Receipt number | R000000277 |
Scientific Title | Secondary prevention of HMG-CoA reductase inhibitor against stroke |
Date of disclosure of the study information | 2005/09/13 |
Last modified on | 2019/06/12 10:58:01 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/09/13 15:17:59 | ||
2 | Update | 2010/03/18 11:03:05 | Last name of contact person Last name of contact person |
|
3 | Update | 2010/03/18 11:05:54 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
4 | Update | 2011/10/26 10:10:50 | Post marketing survey by drug manufacture etc., specified by Japanese law. Tel1 |
|
5 | Update | 2011/10/26 10:12:05 | Tel1 |
|
6 | Update | 2016/02/24 10:47:58 | UMIN ID1 |
|
7 | Update | 2016/03/18 14:17:31 | Email Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
8 | Update | 2016/03/18 14:51:26 | Name of person sending information |
|
9 | Update | 2017/09/22 09:18:41 | Name of primary person or sponsor Organization Category of Funding Organization |
|
10 | Update | 2017/09/22 09:23:13 | Recruitment status Date trial data considered complete Date analysis concluded Publication of results URL related to results and publications |
|
11 | Update | 2019/05/07 13:24:00 | UMIN ID2 |
|
12 | Update | 2019/05/07 15:52:32 | Recruitment status Date of IRB |
|
13 | Update | 2019/06/12 10:58:01 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Zip code Address Address Last name of contact person Last name of contact person Organization Organization Zip code Address Address Organization Organization Address1 Organization Organization Address Address Tel |